ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,919Medicare Part D Prescriptions Filled, Including Refills

Rank: 454 out of 2888

$1.03M Total Retail Price of All Prescriptions

Rank: 204 out of 2888

608 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 608 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

12% of this provider’s 608 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,074 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$95 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 389 360 1 2
LEVOTHYROXINE SODIUM 362 348 2 1
SYNTHROID 357 342 3 52
AMLODIPINE BESYLATE 343 337 4 5
PRAVASTATIN SODIUM 252 248 5 12
METFORMIN HCL 211 204 6 8
ATORVASTATIN CALCIUM 208 196 7 9
LISINOPRIL 202 180 8 3
HYDROCODONE-ACETAMINOPHEN 193 149 S3 9 4
ZOLPIDEM TARTRATE 191 165 10 17
OMEPRAZOLE 179 174 11 7
HYDROCHLOROTHIAZIDE 173 157 12 15
METOPROLOL SUCCINATE 160 155 13 11
NEXIUM 149 132 14 19
DIOVAN HCT 142 135 15 61
CRESTOR 140 130 16 20
CYMBALTA 136 113 17 44
LOSARTAN POTASSIUM 130 127 18 18
DIOVAN 118 116 19 35
LOSARTAN-HYDROCHLOROTHIAZIDE 109 106 20 46
CLOPIDOGREL 105 105 21 30
FUROSEMIDE 103 94 22 6
LOVASTATIN 103 103 22 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 101 24 28
METOPROLOL TARTRATE 101 101 25 10
ATENOLOL 101 74 25 25
CARVEDILOL 101 100 25 21
NIASPAN 97 97 28 127
CELEBREX 95 95 29 89
ALENDRONATE SODIUM 92 90 30 23
TAMSULOSIN HCL 91 91 31 29
CITALOPRAM HBR 90 85 32 24
GLIMEPIRIDE 87 87 33 36
WARFARIN SODIUM 84 74 34 22
BYSTOLIC 82 75 35 99
LIPITOR 82 82 35 78
ALLOPURINOL 79 78 37 37
TRILIPIX 78 78 38 160
ESCITALOPRAM OXALATE 74 74 39 62
GABAPENTIN 74 70 39 13
ZETIA 74 74 39 81
TRAMADOL HCL 72 72 42 16
PLAVIX 71 71 43 40
LEVOFLOXACIN 71 56 43 57
CIPROFLOXACIN HCL 70 65 45 47
LEVEMIR FLEXPEN 63 57 46 156
FLUOXETINE HCL 62 61 47 83
MELOXICAM 61 60 48 31
NOVOFINE 32 59 58 49 436
CEFDINIR 57 49 50 194
BENICAR HCT 56 56 51 181
POTASSIUM CHLORIDE 55 51 52 14
PANTOPRAZOLE SODIUM 54 52 53 33
PREMARIN 53 51 R 54 129
TRAZODONE HCL 50 49 55 43
EVISTA 50 50 55 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.